Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
HUGO Series 🌟
HUGO-GT™ (Rare Disease Research)
HUGO-Ab™ (Antibody Discovery)
MouseAtlas Model Library
Flash Sales
Research Models
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
Cell Line Models
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Services
Preclinical Efficacy
Neuroscience
Alzheimer's Disease (AD)
Parkinson's Disease (PD)
Huntington's Disease (HD)
Ophthalmology
Oncology
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
Genetically Engineered Animals
Knockout Mice
Transgenic Mice
Knockin Mice
Knockout Rats
Knockin Rats
Transgenic Rats
Model Generation Techniques
Turboknockout® Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Breeding & Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
Custom Cell Line Services
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Modalities
Gene Therapy
AI-Powered AAV Discovery
Oligonucleotide Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
About Us
Corporate Overview
Facility Overview
Animal Health & Welfare
Health Reports
Our Partners
Careers
Contact Us
Login
Genetic Disorders and Genomics

Knockout Cell Line FAQ: Design, Strategy, and Validation

Cyagen Technical Content Team | July 18, 2025
--
--
--
Contents
01. To achieve gene loss of function, should I perform RNAi knockdown or knockout? 02. What is the difference between monoclonal knockout (KO) cell lines and KO cell pools? 03. Frameshift mutation and fragment knockout - which is better for disabling the target protein’s functional domain? 04. Can we ensure that the protein is not expressed? 05. How to design the experimental strategy when performing a genetic rescue experiment 06. What are the tips for accelerating cell line development? 07. How can Cyagen Help You with Gene Knockout Cell Lines?

Gene knockout (KO) cell lines enable researchers to study the role of specific genes by comparing the phenotypic differences among the knockout and wildtype cells. Herein, we have collected the Frequently Asked Questions on knockout cell line generation, hoping to help researchers gain a proper understanding of how knockout cell lines are developed and used.

To achieve gene loss of function, should I perform RNAi knockdown or knockout?

  • When knockout may cause cells to proliferate very slowly or stop growing, or when the detection efficiency of the cell pool stage after cell transfection shows a significant decline, it can be determined that knockout may be fatal, and RNAi is recommended;
  • Due to the existence of some strong functional proteins, even if the expression is downregulated, it still has a strong function. If RNAi cannot produce phenotype all the time, and the previous data shows this gene can produce a phenotype, in this situation, the knockout is recommended. In addition, if the target gene is located in a non-transcriptional region, or the target gene has strong transcriptional efficiency, it cannot be effectively interfered with by RNAi, and knockout is the only choice. Additionally, knockout cells are more suitable for complement experiments.
  • When we use RNAi to perform gene knockdown and observe the change of cell phenotype, further knockouts can still be performed to make the experimental conclusions more convincing.

What is the difference between monoclonal knockout (KO) cell lines and KO cell pools?

In monoclonal (single) knockout (KO) cell clones, all cells are proliferated from one homozygous cell verified by sequencing, and all cells are the same genotype. Knockout cell pool refers to the pool of cells that have not undergone screening and monoclonalization, so it can be understood that this population contains homozygote, heterozygote, and wild-type knockout cells. After obtaining a KO cell pool, researchers need to screen for single knockout cell clones according to the experimental needs.

When it is necessary to remove interfering factors from a cell population, using a monoclonal stable cell line is recommended due to its relatively pure genomic background yielding consistent experimental results. When performing systems biology studies, cell population factors need to be taken into account. At the same time, many experiments use cell pools (mixed clones) to reduce the interference caused by differences between cells and how the various integration sites of monoclonal cell lines could exhibit inconsistent cell behaviors. Therefore, the options to use monoclonal or mixed clonal cell strains are based on the purpose of the experiment(s) planned.

Frameshift mutation and fragment knockout - which is better for disabling the target protein’s functional domain?

Many people think that fragment knockout has a greater impact on the functional domain of the target protein. In fact, both frameshift mutation and fragment knockout can achieve an ideal knockout effect in many cases.

To determine whether it is a fragment knockout or a frameshift mutation, we should consider whether the knockout fragment is a multiple of non-3. In other words, in addition to the knockout region, we should also consider whether the knockout region can cause a frameshift mutation. If the knockout fragment does not cause a frameshift mutation, the protein only lacks the corresponding amino acid sequence of the knockout region, but other regions of the protein are not affected.

Single Guide Molecule (frameshift) Double Guide Molecule (fragment)
Advantages

The design is simple, the plasmid is small, easy to transform, and the cost is low.

It is necessary to design Guide Molecule on exons.

The identification is simple; All gene copies can be deleted uniformly, and the functional analysis is simple.

It is necessary to design Guide Molecule on introns.

Disadvantages Identification is troublesome, sequencing is required, and a non-triple frameshift must be generated, which is difficult to achieve for a few cell lines. The technology is complex, the cost is high, and the knockout efficiency is low. And more monoclonal analysis is needed to screen homozygous cell lines.

Can we ensure that the protein is not expressed?

From a scientific point of view, it is impossible to ensure that any cell does not express a protein, whether using frameshift mutation or fragment knockout strategies. For example, the frameshift mutant mRNAs may undergo variable splicing and skip the frameshift site for translation, resulting in protein expression. Similarly, the site of the protein’s expressed functional domain is just ahead of the cleavage site – permitting continued expression of functional protein.

Therefore, one cannot hastily guarantee that the protein is not expressed. However, we can avoid the problem of residual protein by optimizing the design of Guide Molecule. By combining optimal Guide Molecule design with antibody analysis and phased WB tests during the experimental process, we can provide you with a complete scientific solution for knockout cell lines, so that you no longer need to worry about the problem of residual protein.

How to design the experimental strategy when performing a genetic rescue experiment

First of all, for knockout cells that need to do a rescue experiment, the strategy of stable transformation of Guide Molecule + frameshift is not recommended. This is because Cas9 continues to express, and Guide Molecule acts on the exon system. When performing genetic rescue experiments, frameshift mutations must be used. The cDNA mutations, namely synonymous mutations, remove the PAM sequence recognized by Targeted Gene Editing. Otherwise, the cDNA will also be cleaved. In addition, the fragment knockout means that two Guide Molecules are cleaved on the introns, and the cleavage site is not recognized on the cDNA, so the overexpression recovery experiment is relatively smooth.

What are the tips for accelerating cell line development?

We can increase the serum concentration in the culture medium, or switch to fetal bovine serum, ES serum, or add stimulating factors to the medium; spread a layer of trophoblast cells before plating 96 well for culture.

How can Cyagen Help You with Gene Knockout Cell Lines?

We can perform a variety of knockout (KO) strategies to generate a custom cell line model, including frameshift mutation, large fragment knockout, and multiple genes knockout. We will adopt the best knockout strategy to greatly improve the success rate of target gene knockout and the expression efficiency according to each project's unique requirements.

Subscribe to Receive Updates & Promotions From Cyagen
Subscribe
* Your privacy matters to us. We never share it with third parties.
Explore More
Humanized ABCA4 Models Advance RNA & Gene Editing
From F9 to Function: Validating a New Preclinical Model for Hemophilia B Drug Development
Accelerating the Search for a Cure: A New Preclinical Model for Methylmalonic Acidemia
Driving Translational Success: A Strategic Analysis of C3 and C5 Humanized Mouse Models for Next-Generation Drug Development
Share
Top
Ready to Elevate Your Research?
Discover how Cyagen can support your research. Let’s start a conversation.
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0336
Email:
inquiry@cyagen.com
Models
HUGO-Ab™ (Antibody Discovery)HUGO-GT™ (Rare Disease Research)MouseAtlas Model LibraryResearch Models
Services
NeuroscienceOphthalmologyOncologyMetabolic & Cardiovascular DiseasesAutoimmune & Inflammatory
About Us
Corporate OverviewFacility OverviewAnimal Health & WelfareHealth ReportsOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest
Main Area of Research